Literature DB >> 23573398

Multi-factorial causes of torsade de pointes in a hospitalised surgical patient.

Prashanth Panduranga1, Mohammed Al-Mukhaini, Mamatha P Rajarao.   

Abstract

A 55-year-old chronic alcoholic male known to be positive for human immunodeficiency virus (HIV) was admitted to a surgical ward following perianal abscess drainage. He was noted to have sinus bradycardia, ventricular premature complexes, and mild hypotension. His laboratory investigations revealed mild hypokalaemia. He was intermittently agitated and alcohol withdrawal syndrome (AWS) was diagnosed. Postoperatively, he received intravenous piperacillin/tazobactam and metronidazole infusions along with a small dose of dopamine. Analysis of a 24-hour Holter monitor (ECG) showed a prolonged QT interval with two episodes of self-terminating torsade de pointes. His AWS was treated, hypokalaemia was corrected, and dopamine, along with antibiotics, was withdrawn. There was no recurrence of arrhythmias. This case highlights the importance of avoiding QT-prolonging drugs in hospitalised patients, since hospitalised patients often have multiple risk factors for a proarrhythmic response.

Entities:  

Keywords:  Alcohol withdrawal syndrome; Case report; Human immunodeficiency virus; Oman; QT interval; QT prolongation; QT-prolonging drugs; Torsade de pointes

Year:  2013        PMID: 23573398      PMCID: PMC3616783     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  11 in total

1.  ECG changes amongst patients with alcohol withdrawal seizures and delirium tremens.

Authors:  Florim Cuculi; Richard Kobza; Tobias Ehmann; Paul Erne
Journal:  Swiss Med Wkly       Date:  2006-04-01       Impact factor: 2.193

2.  Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System.

Authors:  Elisabetta Poluzzi; Emanuel Raschi; Domenico Motola; Ugo Moretti; Fabrizio De Ponti
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

3.  Prolongation of the QTc interval during alcohol withdrawal syndrome.

Authors:  E Otero-Antón; A González-Quintela; J Saborido; J A Torre; A Virgós; E Barrio
Journal:  Acta Cardiol       Date:  1997       Impact factor: 1.718

Review 4.  Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Authors:  Barbara J Drew; Michael J Ackerman; Marjorie Funk; W Brian Gibler; Paul Kligfield; Venu Menon; George J Philippides; Dan M Roden; Wojciech Zareba
Journal:  J Am Coll Cardiol       Date:  2010-03-02       Impact factor: 24.094

5.  Long QTc and torsades de pointes in human immunodeficiency virus disease.

Authors:  A G Kocheril; S A Bokhari; W P Batsford; A J Sinusas
Journal:  Pacing Clin Electrophysiol       Date:  1997-11       Impact factor: 1.976

6.  QT interval dispersion and cardiac sympathovagal balance shift in rats with acute ethanol withdrawal.

Authors:  Seiko Shirafuji; Jinyao Liu; Nanako Okamura; Kazuyuki Hamada; Tatsuya Fujimiya
Journal:  Alcohol Clin Exp Res       Date:  2009-11-24       Impact factor: 3.455

7.  Abrupt termination of an ethanol regimen provokes ventricular arrhythmia and enhances susceptibility to the arrhythmogenic effects of epinephrine in rats.

Authors:  Jinyao Liu; Tatsuya Fujimiya
Journal:  Alcohol Clin Exp Res       Date:  2009-12-16       Impact factor: 3.455

8.  Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence.

Authors:  T Yang; D M Roden
Journal:  Circulation       Date:  1996-02-01       Impact factor: 29.690

Review 9.  Alcohol abuse and heart failure.

Authors:  Irma Laonigro; Michele Correale; Matteo Di Biase; Emanuele Altomare
Journal:  Eur J Heart Fail       Date:  2009-03-30       Impact factor: 15.534

10.  Prevalence and risk factors of prolonged QTc interval in HIV-infected patients: results of the HIV-HEART study.

Authors:  Nico Reinsch; Christiane Buhr; Peter Krings; Hagen Kaelsch; Kathrin Neuhaus; Heiner Wieneke; Raimund Erbel; Till Neumann
Journal:  HIV Clin Trials       Date:  2009 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.